FDA Drug Recalls

Recalls / Class II

Class IID-0849-2022

Product

Lidocaine Prilocaine Cream USP, 2.5%/2.5% Net Wt. 30 gram tube, Rx Only, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, NDC 63739-054-66

Affected lot / code info
Lot: 16876, Exp.: 05/31/2023

Why it was recalled

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Recalling firm

Firm
McKesson Corporation dba McKesson Drug Company
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
4853 Crumpler Rd, N/A, Memphis, Tennessee 38141-8301

Distribution

Quantity
1176 tubes
Distribution pattern
Nationwide in the United States including Guam and the Northern Mariana Islands.

Timeline

Recall initiated
2022-04-21
FDA classified
2022-05-05
Posted by FDA
2022-05-11
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0849-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls